Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery.

[1]  M. Price,et al.  Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. , 2012, JAMA.

[2]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[3]  Sean M. O'Brien,et al.  Variation in use of blood transfusion in coronary artery bypass graft surgery. , 2010, JAMA.

[4]  M. Pencina,et al.  Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. , 2010, JACC. Cardiovascular interventions.

[5]  S. de Servi,et al.  Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. , 2010, British journal of anaesthesia.

[6]  M. Eisenberg,et al.  Perioperative management of patients with drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[7]  L. Thuesen,et al.  Late coronary stent thrombosis. , 2010, Minerva medica.

[8]  S. Ellis,et al.  Characterization of post-operative risk associated with prior drug-eluting stent use. , 2009, JACC. Cardiovascular interventions.

[9]  T. Geisler,et al.  Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery , 2009, Clinical Research in Cardiology.

[10]  Jeffrey L. Anderson,et al.  2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[11]  S. Steinhubl,et al.  Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. , 2007, American heart journal.

[12]  Subhash Banerjee,et al.  Perioperative management of patients with coronary stents. , 2007, Journal of the American College of Cardiology.

[13]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[14]  D. Moliterno,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[15]  Patrick Whitlow,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.

[16]  Patrick Whitlow,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  David B Matchar,et al.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.

[18]  Jeroen J. Bax,et al.  Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. , 2007, Journal of the American College of Cardiology.

[19]  Robert M Califf,et al.  A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. , 2006, Journal of the American College of Cardiology.

[20]  I. Palacios,et al.  Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. , 2006, Journal of the American College of Cardiology.

[21]  J. Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.

[22]  W. Markiewicz,et al.  Late thrombosis of sirolimus‐eluting stents following noncardiac surgery , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  Patrick W Serruys,et al.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents. , 2005, Journal of the American College of Cardiology.

[24]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[25]  P. Vaitkus,et al.  Risks of noncardiac surgery after coronary stenting. , 2005, The American journal of cardiology.

[26]  Patrick W Serruys,et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.

[27]  R. Waksman,et al.  Major noncardiac surgery following coronary stenting: When is it safe to operate? , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  P. Berger,et al.  Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. , 2003, Journal of the American College of Cardiology.

[29]  D. Baim,et al.  Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.

[30]  A. Raizner,et al.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting. , 2000, Journal of the American College of Cardiology.

[31]  N. Orford,et al.  Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. , 2007, British journal of anaesthesia.

[32]  Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. , 1998, The New England journal of medicine.